Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/28819
Full metadata record
DC FieldValueLanguage
dc.contributor.authorThomaere, Eveline-
dc.contributor.authorDehairs, Michiel-
dc.contributor.authorLAENEN, Annouschka-
dc.contributor.authorMehrsima, Abdoli-
dc.contributor.authorTimmerman, Dirk-
dc.contributor.authorCornelissen, Sandra-
dc.contributor.authorOp de Beeck, Katya-
dc.contributor.authorBosmans, Hilde-
dc.contributor.authorMaleux, Geert-
dc.date.accessioned2019-07-25T11:31:15Z-
dc.date.available2019-07-25T11:31:15Z-
dc.date.issued2018-
dc.identifier.citationACTA RADIOLOGICA, 59(12), p. 1446-1450-
dc.identifier.issn0284-1851-
dc.identifier.urihttp://hdl.handle.net/1942/28819-
dc.description.abstractBackground: Uterine fibroid embolization (UFE) is a minimally invasive imaging-guided treatment using radiation exposure. Purpose: To compare the patients' radiation exposure during UFE before and after introduction of a new X-ray imaging platform. Material and Methods: Forty-one patients were enrolled in a prospective, comparative two-arm project before and after introduction of a new X-ray imaging platform with reduced dose settings, i.e. novel real-time image processing techniques (AlluraClarity). Demographic, pre-interventional imaging, and procedural data, including dose area product (DAP) and estimated organ dose on the ovaries and uterus, were recorded and angiographic quality of overall procedure was assessed. Results: There were no significant differences in demographic characteristics and preoperative fibroid and uterine volumes in the two groups. The new imaging platform led to a significant reduction in mean total DAP (102 vs. 438 Gy.cm(2); P < 0.001), mean fluoroscopy DAP (32 vs. 138 Gy.cm(2); P < 0.001), mean acquisition DAP (70 vs. 300 Gy.cm(2); P < 0.001), and acquisition DAP estimated organ dose in ovaries (42 vs. 118 mGy; P < 0.001) and uterus (40 vs. 118 mGy, P < 0.001), without impairment of the procedure and angiographic image quality. Conclusion: A substantial 77% reduction of DAP values and 64% and 66% reduction in organ dose on ovaries and uterus, respectively, was demonstrated with the new imaging platform, while maintaining optimal imaging quality and efficacy.-
dc.language.isoen-
dc.publisherSAGE PUBLICATIONS LTD-
dc.rightsThe Foundation Acta Radiologica 2018-
dc.subject.otherGenital / reproductive system female-
dc.subject.otherinterventional vascular-
dc.subject.otherradioprotection / radiation dose-
dc.subject.othercatheter arteriography-
dc.subject.otherembolization-
dc.subject.otherradiation safety-
dc.titleA new imaging technology to reduce the radiation dose during uterine fibroid embolization-
dc.typeJournal Contribution-
dc.identifier.epage1450-
dc.identifier.issue12-
dc.identifier.spage1446-
dc.identifier.volume59-
local.format.pages5-
local.bibliographicCitation.jcatA1-
dc.description.notes[Thomaere, Eveline; de Beeck, Katya Op] Katholieke Univ Leuven, Dept Radiol, Univ Hosp Leuven, Dept Imaging & Pathol, Leuven, Belgium. [Dehairs, Michiel; Bosmans, Hilde] Katholieke Univ Leuven, Sect Med Phys, Dept Radiol, Univ Hosp Leuven,Dept Imaging & Pathol, Leuven, Belgium. [Laenen, Annouschka] Katholieke Univ Leuven, Interuniv Ctr Biostat & Stat Bioinformat, Leuven, Belgium. [Laenen, Annouschka] Univ Hasselt, Leuven, Belgium. [Mehrsima, Abdoli] Philips Healthcare, Eindhoven, Netherlands. [Timmerman, Dirk] Univ Hosp Leuven, Dept Gynecol, Leuven, Belgium. [Cornelissen, Sandra; Maleux, Geert] Katholieke Univ Leuven, Dept Radiol, Sect Intervent Radiol, Univ Hosp Leuven,Dept Imaging & Pathol, Herestr 49, B-3000 Leuven, Belgium.-
local.publisher.place1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1177/0284185118760064-
dc.identifier.isi000453426300012-
dc.identifier.eissn1600-0455-
local.uhasselt.internationalyes-
item.accessRightsRestricted Access-
item.fulltextWith Fulltext-
item.contributorThomaere, Eveline-
item.contributorDehairs, Michiel-
item.contributorLAENEN, Annouschka-
item.contributorMehrsima, Abdoli-
item.contributorTimmerman, Dirk-
item.contributorCornelissen, Sandra-
item.contributorOp de Beeck, Katya-
item.contributorBosmans, Hilde-
item.contributorMaleux, Geert-
item.fullcitationThomaere, Eveline; Dehairs, Michiel; LAENEN, Annouschka; Mehrsima, Abdoli; Timmerman, Dirk; Cornelissen, Sandra; Op de Beeck, Katya; Bosmans, Hilde & Maleux, Geert (2018) A new imaging technology to reduce the radiation dose during uterine fibroid embolization. In: ACTA RADIOLOGICA, 59(12), p. 1446-1450.-
crisitem.journal.issn0284-1851-
crisitem.journal.eissn1600-0455-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
thomaere2018.pdf
  Restricted Access
Early view185.32 kBAdobe PDFView/Open    Request a copy
Show simple item record

SCOPUSTM   
Citations

1
checked on Sep 3, 2020

WEB OF SCIENCETM
Citations

7
checked on Mar 23, 2024

Page view(s)

160
checked on May 30, 2023

Download(s)

116
checked on May 30, 2023

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.